XAIR Beyond Air, Inc.
2.540USD-0.39%Mkt Cap: 2.50M $P/E: —1d ago
Beyond Air, Inc. operates as a commercial-stage medical device and biopharmaceutical company. It operates through Beyond Air, Beyond Cancer, and NeuroNos segments. The company offers Lungfit PH for the treatment of persi…
Industry Peers
Medical DevicesKey Statistics
Company
Market Cap2.50M USD
Enterprise Value17.07M USD
Revenue (TTM)7.69M USD
Gross Profit252.00K USD
Net Income (TTM)-33.25M USD
Revenue/Share14.43 USD
Last Price2.540 USD
Fiscal Year EndMar 2026
MR QuarterJun 2026
Employees54
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-1.54
PEG—
EV/EBITDA-0.69
EV/Revenue2.22
P/S0.33
P/B0.95
EPS (TTM)-64.40
EPS (Forward)-1.66
52W Range
2.3800% of range55.60
52W High55.60 USD
52W Low2.380 USD
Profitability
Gross Margin3.28%
Oper. Margin-373.98%
EBITDA Margin0.00%
Profit Margin-432.99%
ROE-542.75%
ROA-93.96%
Growth
Revenue Growth0.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF-18.14M USD
CapEx (TTM)1.02M USD
FCF Margin-183.05%
FCF Yield-562.76%
Net Debt13.79M USD
Net Debt/EBITDA-0.56
Balance Sheet
Debt/Equity3.82
Current Ratio3.31
Quick Ratio1.60
Book Value/Sh2.69 USD
Cash/Share10.25 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay DateJan 10, 2017
Splits
Last Split1:20
Split DateJul 13, 2026
Analyst Consensus
Rating—
Target (Mean)20.00 USD
Upside (mean)+687.4%
Target Range10.00 USD – 30.00 USD
10.00+687.4% to mean30.00
# Analysts2
Ownership
Shares Out.984.41K
Float764.20K
Insiders22.38%
Institutions7.00%
Short Interest
Short Ratio0.1d
Short % Float6.11%
Short % Out.6.03%
Shares Short59.32K
Short (prev mo.)27.57K
Technical
SMA 504.344 (-41.5%)
SMA 20012.08 (-79.0%)
Beta0.21
S&P 52W Chg16.45%
Avg Vol (30d)84.07K
Avg Vol (10d)134.16K
Technical Indicators
RSI (14)30.6
MACD-0.5540
MACD Signal-0.6215
MACD Hist.+0.0675
BB Upper3.527 USD
BB Middle2.990 USD
BB Lower2.454 USD
BB Width35.90%
ATR (14)0.3280 USD
Vol Ratio (20d)0.44x